Loading...
The URL can be used to link to this page
Your browser does not support the video tag.
Home
My WebLink
About
10.13.25 Board Correspondence - FW_ Dr. Rimas Jankunas Explores Flawed Trials and COVID Injection Harms
.ATTENTION: This message originated from outside Butte County. Please exercise judgment before opening attachments, clicking on links, or replying.. From:Clerk of the Board To:Mutony, Heather Cc:Lee, Lewis Subject:Board Correspondence - FW: Dr. Rimas Jankunas Explores Flawed Trials and COVID Injection Harms Date:Monday, October 13, 2025 9:31:30 AM Please see Board Correspondence - From: lance dreiss <lancedreiss@att.net> Sent: Monday, October 13, 2025 6:37 AM To: Shared Mailbox Clerk of the Board <pcbs@countyofplumas.com>; Soderstrom, Monica <msoderstrom@buttecounty.net>; Assemblymember.Gallagher@assembly.ca.gov; Senator.Dahle@senate.ca.gov; davidhollister@countyofplumas.com; sheriff@countyofplumas.com; District Attorney <DA@buttecounty.net>; Kimmelshue, Tod <TKimmelshue@buttecounty.net>; Pickett, Andy <APickett@buttecounty.net>; Connelly, Bill <BConnelly@buttecounty.net>; Teeter, Doug <DTeeter@buttecounty.net>; Julie Threet <julie4butte5@gmail.com>; Waugh, Melanie <mwaugh@buttecounty.net>; Kitts, Melissa <mkitts@buttecounty.net>; Durfee, Peter <pdurfee@buttecounty.net>; Ritter, Tami <TRitter@buttecounty.net>; Teri DuBose <Teri.DuBose@mail.house.gov>; Congressman Doug LaMalfa <CA01DL.Outreach@mail.house.gov>; Stephens, Brad J. <BStephens@buttecounty.net>; Clerk of the Board <ClerkoftheBoard@buttecounty.net> Subject: Fwd: Dr. Rimas Jankunas Explores Flawed Trials and COVID Injection Harms Public Record diana dreiss Begin forwarded message: From: Dr Mark Trozzi <drtrozzi@substack.com> Date: October 13, 2025 at 6:31:28 AM PDT To: lancedreiss@att.net Subject: Dr. Rimas Jankunas Explores Flawed Trials and COVID Injection Harms Reply-To: Dr Mark Trozzi <reply+2viodv&kcryl&&b3316419fc04b2329a4a88cffbb339b0728b86607f58a563f88bd f3d080274e9@mg1.substack.com> Dr. Jankunas highlights manipulated studies, failed oversight, and catastrophic harms during the COVID “pandemic”͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ Forwarded this email? Subscribe here for more Dr. Rimas Jankunas ExploresFlawed Trials and COVIDInjection Harms Dr. Jankunas highlights manipulated studies, failed oversight, and catastrophic harms during the COVID “pandemic” DR MARK TROZZI MD OCT 13 READ IN APP Having served as deputy director of the Lithuanian State Medicines Control Agency, Dr. Rimas Jankunas has deep expertise in clinical trials, drug regulation, and pharmacovigilance. He highlights how flawed trial design, regulatory capture, and failed safety surveillance created a system that concealed dangers while promoting mass injection campaigns. The World Council for Health (WCH) is an independent, non-profit organization dedicated to empowering people with trustworthy information about health and sovereignty, enabling them to make meaningful and informed choices. Supporting the WCH is an investment in your health, your family’s well-being, and our collective freedom. Learn more at worldcouncilforhealth.org and consider contributing at worldcouncilforhealth.org/donate. There are now 41 WCH Country Councils around the world, and the number continues to grow: view them here. We are deeply grateful to WCH Estonia for organizing and hosting this important conference. Dr. Rimas Jankunas is a Lithuanian pharmacologist with more than 30 years of medical experience: Researcher Profile: lsmu.lt Institute Page: archyvas.lsmu.lt Flawed Clinical Trials and Misleading Efficacy Dr. Rimas Jankunas demonstrates that the clinical trials used to authorize the COVID “vaccines” were structurally unsound. Trial stratification placed individuals aged 16 to 64 into the same category, erasing meaningful distinctions between groups with vastly different risks. Those whom the “vaccines” were allegedly meant to benefit most—the elderly—were severely underrepresented. Follow-up periods averaged only three to four months, an interval far too short to detect delayed adverse events. Dr. Jankunas says that the often cited 91% efficacy figure was based on relative risk reduction, masking the reality that the absolute risk reduction was as low as 2–3%. Such omissions violated European Medicines Agency guidelines requiring disclosure of absolute benefit. Conditional Authorization and GovernmentMisinformation The products received conditional marketing authorization, bypassing full evaluations of efficacy and safety. No trials were conducted on their impact on transmission. Despite this, Dr. Jankunas explains, the Estonian government declared the injections 100% effective against hospitalization and death. Pharmacovigilance Breakdown Dr. Jankunas exposes the collapse of pharmacovigilance systems meant to protect public health. In Lithuania, regulators recorded only 35 deaths following COVID “vaccination,” while national statistics reported nearly 5,000 deaths within three months of injection. This suggests that fewer than 1% of adverse events were acknowledged. Similar patterns appeared across Europe, where reporting rates also fell below 1%. Independent initiatives to encourage citizens to file reports were actively obstructed, resulting in the loss of critical safety data. Case Study: A Preventable Tragedy To illustrate real-world consequences, Dr. Jankunas presents the case of a 17-year-old male who died from cerebral venous sinus thrombosis after receiving a COVID “vaccine.” The condition was initially misdiagnosed as migraine, and by the time appropriate treatment was attempted, it was too late. Laboratory findings revealed abnormal coagulation, extremely high antibody titers, and elevated cardiac markers. Spike protein expression can provoke autoimmune reactions and clot formation, a mechanism consistent with numerous reports of thrombosis documented in European safety databases. Despite the 17-year-old meeting the criteria for a “vaccine”-related death report, no such report was filed. Final Warnings and Recommendations Dr. Jankunas concludes with urgent recommendations. Long-term efficacy and safety endpoints must be mandatory in all vaccine trials. Fatal and life- threatening events following “vaccination” should undergo independent review, with clinicians trained to recognize unexpected reactions. He also stresses that transparency and accountability are essential to prevent repeats of past medical disasters such as thalidomide. Ultimately, the failures of trial design, regulatory oversight, and pharmacovigilance during the COVID “pandemic” represent not isolated mistakes but systemic breakdowns that demand urgent correction. Related Material The COVID Crimes: A Timeline of MedicalFraud and Harm DR MARK TROZZI MD ·JUL 23 Read full story From the Vault | The True “Efficacy” ofCOVID-19 “Vaccines” DR MARK TROZZI MD ·MAY 7, 2024 Read full story Dr Paul Alexander exposes criminality ofGov, Pfizer and FDA DR MARK TROZZI MD ·APRIL 5, 2022 Read full story This is not a vaccine This is not a vaccine DR MARK TROZZI MD ·JANUARY 23, 2021 Read full story You're currently a free subscriber to Dr Trozzi. For the full experience, upgrade your subscription. Upgrade to paid LIKE COMMENT RESTACK © 2025 Dr Mark Trozzi Unsubscribe